Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
ObjectiveThe aim of this study was to explore the effect of depression and selective serotonin reuptake inhibitors on implant osseointegration and bone healing.MethodsForty‐eight 6‐ to 8‐week‐old SPF Sprague–Dawley male rats were randomly divided into four groups: the Control group, the Fluoxetine group, the Depression group and the De&Flu group. The rats in the Depression group and the De&Flu group were subjected to a depression modelling process, and the rats in the Control group and the Fluoxetine group were raised normally. Then, a titanium implant was placed in the right tibia of each rat. In the Fluoxetine group and De&Flu group, fluoxetine was injected subcutaneously daily, while subcutaneously injecting physiological saline in the Control group and Depression group. Collecting serum from the rats used for ELISA. The surgical area was cut for microcomputed tomography and histology observation.ResultsAfter 12 weeks, bone mineral density was lower in the De&Flu group than in the Control group, Depression group and Fluoxetine group. Bone mineral density was also lower in the Depression group and the Fluoxetine group than in the Control group. The percentage of bone–implant contact (BIC%) in De&Flu rats was lower than in the Control, Depression and Fluoxetine groups. The BIC% in the Depression group and the Fluoxetine group was lower than in the Control group.ConclusionsDepression and fluoxetine negatively affect bone density and implant osseointegration independently, and this damaging effect is exacerbated when both factors are present. The mechanism may be related to the dysregulation of the hypothalamic–pituitary–adrenal axis and inflammation in the body.
ObjectiveThe aim of this study was to explore the effect of depression and selective serotonin reuptake inhibitors on implant osseointegration and bone healing.MethodsForty‐eight 6‐ to 8‐week‐old SPF Sprague–Dawley male rats were randomly divided into four groups: the Control group, the Fluoxetine group, the Depression group and the De&Flu group. The rats in the Depression group and the De&Flu group were subjected to a depression modelling process, and the rats in the Control group and the Fluoxetine group were raised normally. Then, a titanium implant was placed in the right tibia of each rat. In the Fluoxetine group and De&Flu group, fluoxetine was injected subcutaneously daily, while subcutaneously injecting physiological saline in the Control group and Depression group. Collecting serum from the rats used for ELISA. The surgical area was cut for microcomputed tomography and histology observation.ResultsAfter 12 weeks, bone mineral density was lower in the De&Flu group than in the Control group, Depression group and Fluoxetine group. Bone mineral density was also lower in the Depression group and the Fluoxetine group than in the Control group. The percentage of bone–implant contact (BIC%) in De&Flu rats was lower than in the Control, Depression and Fluoxetine groups. The BIC% in the Depression group and the Fluoxetine group was lower than in the Control group.ConclusionsDepression and fluoxetine negatively affect bone density and implant osseointegration independently, and this damaging effect is exacerbated when both factors are present. The mechanism may be related to the dysregulation of the hypothalamic–pituitary–adrenal axis and inflammation in the body.
No abstract
Introduction:Prior research has indicated a correlation between hypothalamic-pituitary endocrine secretion and bone health. However, the relationship between thyroid hormone levels and lumbar spine bone density in adults remains incompletely understood. The objective of the present study was to examine this relationship and to assess the moderating effects of factors such as gender, age, and depressive symptoms on it. Methods:Cross-sectional analyses were conducted using data from the National Health and Nutrition Examination Survey (NHANES), conducted between 2007 and 2012. Weighted linear regression models and multiple logistic regression models were employed to evaluate the correlation between lumbar spine bone density and indicators of thyroid function in 4996 adults aged 20-80 years. Additionally, the study investigated the effect of thyroid hormones on lumbar spine bone density in depressed adults. Results and conclusions:In adults, a significant negative correlation was observed between lumbar spine bone density and FT3 levels, but not with any of the other thyroid hormones. The correlation between lumbar bone density and TT3, TT4, and Tg was found to be interactive with regard to gender. No significant interaction was observed between age and depressive symptoms with regard to lumbar bone density and thyroid hormones. Subgroup analyses revealed that the inverse relationship between bone mineral density (BMD) and free triiodothyronine (FT3) was exclusive to younger adults and was not statistically significant in older adults. In the fully adjusted model, a significant negative correlation was observed between BMD and TT4 in adult males (p=0.027), whereas no significant correlation was identified in adult females. In the fully adjusted model, BMD was significantly negatively correlated with FT4 and FT3 in non-depressed patients (p=0.040, p=0.027). Additionally, it was found that although thyroid hormones correlate with both depression and BMD, thyroid hormones do not cause changes in BMD solely because of depressive states. Therefore, further comprehensive research is required to elucidate the specific mechanism of hypothalamic-pituitary-thyroid on bone health.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.